Recognized standard
F749-20
FDA recognition 2-274 · ASTM · Biocompatibility
Key facts
| Recognition number | 2-274 |
|---|---|
| Designation | F749-20 |
| Title | Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit |
| Standards developer | ASTM International |
| Specialty area | Biocompatibility |
| Date of entry | Jul 6, 2020 |
| Scope (excerpt) | 1.1 This practice is an intracutaneous reactivity test used to assess the potential of the material under test to produce irritation following intradermal injections of extracts of the material. 1.2 The liquids injected into the rabbits are those obtained by Practice F619 where the extraction… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: